874 Development of BCA101, a bifunctional antibody capable of simultaneously disabling EGFR and TGFβ signaling, as novel single-agent immunotherapy

874 Development of BCA101, a bifunctional antibody capable of simultaneously disabling EGFR and TGFβ signaling, as novel single-agent immunotherapy

Bibliographic Details
Main Authors: Chaitali Dey, Srinivas Reddy Boreddy, Reshmi Nair, Arindam Banerjee, Anshu Kuriakose, Prashant Kumar Pandey, Meena Shri, Shruthi Rao, Bhadravathi Marigowda Shivakumar, Moni Abhram Kuriakose, Ram Bhupal Reddy, Amritha Suresh, Praveen Reddy Moole, Usha Bughani, Seng-Lai Tan, Pradip Nair
Format: Article
Language:English
Published: BMJ Publishing Group 2021-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items